Janus Henderson Group PLC Cabaletta Bio, Inc. Transaction History

Janus Henderson Group PLC

  • $187 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$7.22 - $18.82 $1,285 - $3,349
-178 Reduced 0.91%
19,400 $145,000
Q1 2024

May 15, 2024
BUY
$16.79 - $25.38 $319 - $482
19 Added 0.1%
19,578 $334,000
Q4 2023

Feb 14, 2024
SELL
$12.21 - $23.36 $463 - $887
-38 Reduced 0.19%
19,559 $443,000
Q3 2023

Nov 14, 2023
BUY
$11.84 - $18.65 $232,028 - $365,484
19,597 New
19,597 $298,000

Others Institutions Holding CABA

# of Institutions
142
Shares Held
50.2M
Call Options Held
18.9K
Put Options Held
41.5K
View Full List

About Cabaletta Bio, Inc.

CABA Quotes by TradingView
  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $115M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email